A fluorogenic hypoxia-activated prodrug strategy for targeted compound delivery and imaging of tumours

<p>Hypoxia, a common feature in solid tumours, is associated with aggressive phenotypes, decreased genomic stability, and with increased resistance to all forms of cancer therapy. The significant differences between the hypoxic microenvironment, and normal tissues, present a therapeutic opport...